Press Releases

April 27, 2017
Washington, DC, April 27, 2017 - Friends of Cancer Research (Friends) would like to thank Chairman Alexander and the Senate HELP Committee for voting to report Dr. Scott Gottlieb's nomination to be…
April 20, 2017
Washington, DC, April 20, 2017 - Friends of Cancer Research (Friends) Chairperson & Founder, Ellen V. Sigal, will receive the Face of Hope award at LUNGevity's Celebration of Hope event tomorrow…
April 5, 2017
Today, at 10am ET, Dr. Scott Gottlieb, the President's nominee for FDA Commissioner, will appear before the Senate Health, Education, Labor and Pensions (HELP) Committee for his confirmation hearing…
March 27, 2017
Washington, DC, March 27, 2017 - Today, Friends of Cancer Research (Friends) launched a new online learning community, ProgressForPatients.org. The site is home to two new programs Friends has been…
March 22, 2017
The first House PDUFA reauthorization hearing is scheduled to take place at 10:15 am ET today, Wednesday, March 22, 2017, in the U.S. House of Representatives. Friends of Cancer Research President…
March 21, 2017
Washington, D.C., March 21, 2017—The National Organization for Rare Disorders (NORD) and Friends of Cancer Research, two leading organizations that collectively represent millions of Americans with…
March 10, 2017
President Nominates Dr. Scott Gottlieb for FDA CommissionerFriends Urges Swift Confirmation Washington, DC, March 10, 2017 - Friends of Cancer Research (Friends) strongly supports President Trump's…
December 9, 2016
Historic Innovation Bill to be Signed Into Law: House, Senate & White House, Unified, Pass Major Bipartisan Action in Final Days of the 114th Congress & Obama Administration Bill Secures…
October 17, 2016
Collaborative Program Will Provide Support for Quality-of-Life Research for Cancer Survivors Vice President Joe Biden released today a final report on the Cancer Moonshot Task Force, naming the…
October 5, 2016
October 5, 2016 - Washington, DC - Today, Friends of Cancer Research (Friends) is co-hosting a summit with the Parker Institute for Cancer Immunotherapy titled, Optimizing the Use of Immunotherapy.…